Galectin Therapeutics shares fall 2.22% after-hours following a $10 million credit line announcement.

Galectin Therapeutics Inc. dropped 2.22% in after-hours trading. The company announced a new $10 million unsecured line of credit facility with Richard E. Uihlein, Chairman of Galectin Board of Directors, and its largest individual stockholder. The credit line is unsecured and at the Company's discretion through April 30, 2026, with interest at the Applicable Federal Rate for short-term loans, which is currently 4.05%, plus 2%.